Clot-Busting device trial halted after just one patient
NCT ID NCT05992168
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial tested a stent-retriever device to remove blood clots from the lungs in people with acute pulmonary embolism. Only one participant was enrolled before the study was terminated. The goal was to see if the device could reduce heart strain and avoid major complications within 48 hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stent-Retriever device
What this could lead to
If successful, this device could offer a new way to quickly remove dangerous blood clots from the lungs, potentially reducing heart strain and complications.
What could go wrong
The trial was terminated early with only 1 participant, so results are very limited. The device may not be safe or effective for broader use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PE - PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People'S Hospital
Beijing, China